By Elizabeth Murphy, Manager of Business Development, LSN

Life Science Nation (LSN) recognizes how Tech Hubs – global incubators and accelerators – are impact entrepreneurs for success, and in turn, close collaboration with these groups and their constituent companies add a value to partnering events, like RESI Partnering Week. Over the last year, LSN has hosted Tech Hubs such as AZ Bio, Women in Bio, and Lyonbiopole and their constituents have had the opportunity to meet the investors and strategic partners who are part of the RESI community. Get to know these Tech Hubs and check out the opportunities available to constituents of those participating in the RESI Partnering Week Global Tech Hub Gathering:

We are currently offering two programs to accelerate Tech Hub involvement and help fund constituents:

• 50% discount on any RESI conference registration for early-stage constituent companies from participating Tech Hubs
• Group Fundraising Package ($1,500 per company) for Tech Hubs including:
• 3-month access to the Investor Database
• Registration at RESI
• Participation in the Innovator’s Pitch Challenge

The Arizona Bioindustry Association (AZBio)

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona’s life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed. AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations. Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and MedTech community.

Lyonbiopole

As a Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne-Rhône-Alpes region. It’s supporting ambitious projects and innovative companies in the healthcare and life sciences sectors. Its aim is to help innovators develop new technologies, products, and services in a push toward a more personalized medicine and better treatments for patients. Its four strategic areas include human medicine, veterinary medicine, in vitro diagnostics, and medical devices and medical technologies.

Women in Bio (WIB)

Women in Bio is an incubator of North American women in the life science industry. WIB aims to help women achieve the highest levels of leadership, influence and decision-making that they desire. As WIB grows its membership, its activities, and its geographic spread, it is rapidly becoming a leading authority and organization for women in the life sciences. Their focuses are on education, mentoring and networking, and on creating opportunities for leadership that can help advance careers. In the past WIB has been an incredible addition to the RESI conferences, sending esteemed life science women entrepreneurs to connect with investors specific to their indication. We look forward to working with them back again at future RESI conferences.

If your Tech Hub is looking for ways to add value to fundraising constituents, connect with the LSN business development team to see which offerings best fit your needs and the companies in your community. LSN shares the mission of global Tech Hubs in seeing promising technologies advance from the lab to the clinic, and into the hands of providers and their patients.

Want to learn more? The business development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International & MA (USA)	West Coast (USA)	East Coast (USA)	Midwest (USA) & Canada
Greg Mannix Vice President International Business Development Book a Meeting!	Candice He  Global Investment Strategist Book a Meeting!	Elizabeth Murphy Manager of Business Development Book a Meeting!	Antoinette Lowre Manager of Business Development Book a Meeting!

The firm is a venture capital fund founded in 1996 with offices in the US, China, and Japan. The firm has over $4.2B assets under management and has invested in over 400 companies. In 2019, the firm closed Fund IX at $780M, its largest fund to date. The firm invests mainly in early-stage technology companies (i.e. internet, SaaS, consumer-tech, etc.) with high disruptive potential and seeks to be the first institutional investor, but dedicates a small amount of capital (about 20% of the fund) to later-stage companies as well. Typically, first checks fall in the $2-5M range in Seed to Series A rounds, but the firm has made investments as small as $250K. Overall, the firm invests in over 20 companies per year across North America and Asia. In terms of healthtech specifically, the firm aims to make at least 1-2 USA-based and 1 China-based investments per year.

The firm is mainly interested in digital health opportunities and will not consider therapeutics or medical devices. The firm will stray away from anything that involves FDA regulatory approval. Previous investments of the firm include a Google Glass-powered remote scribe platform that improves the workflow of physicians, an AI engine that matches cancer patients with clinical trials, a wearable health tracker for healthy lifestyle management, etc. Companies do not need to be generating revenue prior to investment.

The firm invests in private companies with strong technology and can work with different kinds of management teams that are ideally devoted full-time to the company. The firm will almost always act as the lead investor and seek board representation, staying actively involved in their portfolio companies. The firm prefers to have a syndicate of co-investors invest alongside the firm, but this is not an absolute requirement.

If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.

By Karen Deyo, Director of Investor Research, Israel BD, LSN

The summer flying by means one thing: RESI Partnering Week is on its way, and with it comes an avalanche of opportunities to meet with the many investors already signed up! The virtual RESI events have been met with growing interest from early-stage investors, as it provides them with opportunities to invest globally despite the travel restrictions. CB Insights recently reported that investments, both in numbers and investment dollars, have both risen steadily in the past year, indicating that there are plenty of funds out there for fundraising CEOs to tap into.

Check out the latest list of investors attending RESI Partnering Week, including Digital RESI September, RESI AI, and RESI Longevity, September 13-17, and take advantage of the early bird rate ending next week.

RPW Sept. 2021 Confirmed Investors
Confirmed RESI Investors	Confirmed RESI AI Investors	Confirmed RESI Longevity Investors

By Antoinette Lowre, Manager of Business Development, LSN

Over the last several years, a record number of exciting life sciences start-ups have come online. Most of these start-up companies need scientific instrumentation to support their research. But when funds are limited, how can these companies get the instrumentation needed to hit their growth milestones?

Bold View Capital is hosting a workshop as part of the Service Provider Showcase at Digital RESI, September 13-16. The workshop will kick-off with an overview of the leasing market for start-ups. Expert panel will share their own experiences going through the leasing process and offer valuable lessons learned.

This workshop is valuable for start-up companies:

• That rely on scientific instrumentation
• That are pre-revenue and have limited funds to purchase instrumentation
• For whom traditional financing is not available
• That prefer debt financing to diluting equity

Instructors:

• Darren Platt, President, Demetrix
• Bryan Leavitt, Managing Partner, Fountainhead Investment Partners
• Chad Kobold, Director of Business, Development, Bold View Capital

Join Bold View Capital on Wednesday, September 15 at 1 PM EDT. Sign up by August 6 to save on early bird rates!